NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









FEMSelect

FEMSelect

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.femselect.com/

Last Round

Series B

Extension

May 13, 2025

Total Funding Raised

$14.3M

Company Overview

FEMSelect is a medical technology company that develops minimally invasive surgical systems for the treatment of pelvic organ prolapse.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

pelvic organ prolapsesurgical meshminimally invasive surgeryurogynecologypelvic floor reconstructionmedical devicesurgical systemwomen's healthPOP repairmesh-free surgerysurgical kitspelvic floor disorders

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FEMSelect Comps

Public and private peers based on sector, stage, and business model.

FEMSelect comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

FEMSelect Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionMay 13, 2025
Series BOct 19, 2022
Series AJan 24, 2018
SeedDec 1, 2012

FEMSelect Investors

Notable investors and investment history

FEMSelect investors
InvestorRounds
Nordwand CapitalSeries B Extension
TransPacific Venture PartnersSeries B
Robin Hood VenturesSeries B Extension, Series B
Keiretsu CapitalSeries B
MEDA AngelsSeries B
Keiretsu Forum Mid-AtlanticSeries B
TriventuresSeries B Extension, Series B, Series A

FEMSelect Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

FEMSelect Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about FEMSelect's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range13
Year Founded2012
Last FundingMay 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.